These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 27356668)
1. Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer. Sun P; Jiang Z; Chen X; Xue L; Mao X; Ruan G; Song Y; Mustea A Mol Med Rep; 2016 Aug; 14(2):1465-74. PubMed ID: 27356668 [TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of matriptase in ovarian cancer cells with diverse metastatic potential]. Jiang ZQ; Chen XF; Sun PM; Mao XD; Lin F; Song YY Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):370-4. PubMed ID: 24016481 [TBL] [Abstract][Full Text] [Related]
3. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro]. Huang M; Wang Q; Zhang W; Li DR; Li L Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249 [TBL] [Abstract][Full Text] [Related]
4. Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC). Wu J; Zhao S; Zhang J; Qu X; Jiang S; Zhong Z; Zhang F; Wong Y; Chen H Exp Mol Pathol; 2016 Apr; 100(2):294-302. PubMed ID: 26896649 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton. Tang Z; Zhang N; Di W; Li W Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells. Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456 [TBL] [Abstract][Full Text] [Related]
7. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells]. Wang SM; Li L; Zhang W; Li DR; Tang BJ Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):598-602. PubMed ID: 21029616 [TBL] [Abstract][Full Text] [Related]
9. Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX. Ma J; Scott CA; Ho YN; Mahabaleshwar H; Marsay KS; Zhang C; Teow CK; Ng SS; Zhang W; Tergaonkar V; Partridge LJ; Roy S; Amaya E; Carney TJ Elife; 2021 Jun; 10():. PubMed ID: 34165081 [TBL] [Abstract][Full Text] [Related]
10. Silencing of cyclooxygenase-2 inhibits the growth, invasion and migration of ovarian cancer cells. Lin Y; Cui M; Xu T; Yu W; Zhang L Mol Med Rep; 2014 Jun; 9(6):2499-504. PubMed ID: 24718658 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of antisense Snail on invasion and migration of ovarian carcinoma cells]. Jin HY; Feng YJ Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):400-3. PubMed ID: 16008892 [TBL] [Abstract][Full Text] [Related]
12. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin]. Gao H; Shi J; Ge SF; DI W Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933 [TBL] [Abstract][Full Text] [Related]
13. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486 [TBL] [Abstract][Full Text] [Related]
14. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer. Gao C; Yao H; Liu H; Feng Y; Yang Z BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464 [TBL] [Abstract][Full Text] [Related]
15. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells]. Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458 [TBL] [Abstract][Full Text] [Related]
16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells. An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153 [TBL] [Abstract][Full Text] [Related]
18. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model. Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538 [TBL] [Abstract][Full Text] [Related]
19. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells. Lu YM; Rong ML; Shang C; Wang N; Li X; Zhao YY; Zhang SL Oncol Rep; 2013 Mar; 29(3):1133-9. PubMed ID: 23292493 [TBL] [Abstract][Full Text] [Related]
20. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase. Domoto T; Takino T; Guo L; Sato H Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]